Skip to content
← Full study record

NCT01401907 · OUTCOME

Rate of Clinically Significant Depression Symptoms Based on Hospital Anxiety and Depression Scale

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies · Source last updated 2023-10-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Week-12 and Week-24

What was measured

The hospital anxiety and depression scale examines symptoms of depression and anxiety. We compared rates of clinically significant depression symptoms (using a cut off of 8 on the depression subscale score) between study arms at week-12 and week-24.

Analysis population: The two rows examine outcomes at two different time points week-12 and week-24. Please note the number of participants included in week-12 and week-24 analyses reflect the participants who completed the hospital anxiety and depression scale at these time points (study completers), which explains the discrepancy with the flow chart.

Groups in this outcome

Early Palliative Care

Not reported

Standard Oncology Care

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Early Palliative Care138
Standard Oncology Care141

Reported measurements

Week-12

Analysis denominator · Participants

GroupSource count
Early Palliative Care138
Standard Oncology Care141
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Early Palliative Care29Not reportedNot reportedNot reportedNot reported
Standard Oncology Care32Not reportedNot reportedNot reportedNot reported
Week-24

Analysis denominator · Participants

GroupSource count
Early Palliative Care118
Standard Oncology Care122
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Early Palliative Care24Not reportedNot reportedNot reportedNot reported
Standard Oncology Care32Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        29
      2. group Id
        OG001
        value
        32
    denoms
    1. counts
      1. group Id
        OG000
        value
        138
      2. group Id
        OG001
        value
        141
      units
      Participants
    title
    Week-12
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        24
      2. group Id
        OG001
        value
        32
    denoms
    1. counts
      1. group Id
        OG000
        value
        118
      2. group Id
        OG001
        value
        122
      units
      Participants
    title
    Week-24
denoms
  1. counts
    1. group Id
      OG000
      value
      138
    2. group Id
      OG001
      value
      141
    units
    Participants
description
The hospital anxiety and depression scale examines symptoms of depression and anxiety. We compared rates of clinically significant depression symptoms (using a cut off of 8 on the depression subscale score) between study arms at week-12 and week-24.
groups
  1. id
    OG000
    title
    Early Palliative Care
  2. id
    OG001
    title
    Standard Oncology Care
param Type
COUNT_OF_PARTICIPANTS
population Description
The two rows examine outcomes at two different time points week-12 and week-24. Please note the number of participants included in week-12 and week-24 analyses reflect the participants who completed the hospital anxiety and depression scale at these time points (study completers), which explains the discrepancy with the flow chart.
reporting Status
POSTED
time Frame
Week-12 and Week-24
title
Rate of Clinically Significant Depression Symptoms Based on Hospital Anxiety and Depression Scale
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice